Connect with us

Hi, what are you looking for?

Jewish Business News


Mylan chairman due $72 million golden parachute

Mylan’s filing on executive compensation reveals much higher pay than at Teva.

TEVA ,   EREZ VIGODMAN Robert-J-Coury-1 Mylan 320X=p


Mylan (MYL), the generic pharmaceuticals company that is now the object of a hostile takeover bid from Teva Pharmaceutical Industries Ltd. (NYSE: TEVA; TASE: TEVA), reported its senior executives’ compensation at the end of last week. The report is interesting in the light of the exchange between the two companies over the takeover bid. Mylan chairman Robert Coury’s rejection of Teva’s bid cast aspersions on Teva’s corporate culture… [READ MORE]


GLOBES logo-eng (1)Published by Globes [online], Israel business news –

Please help us out :
Will you offer us a hand? Every gift, regardless of size, fuels our future.
Your critical contribution enables us to maintain our independence from shareholders or wealthy owners, allowing us to keep up reporting without bias. It means we can continue to make Jewish Business News available to everyone.
You can support us for as little as $1 via PayPal at
Thank you.







You May Also Like

World News

In the 15th Nov 2015 edition of Israel’s good news, the highlights include:   ·         A new Israeli treatment brings hope to relapsed leukemia...


The Movie The Professional is what made Natalie Portman a Lolita.


After two decades without a rating system in Israel, at the end of 2012 an international tender for hotel rating was published.  Invited to place bids...

VC, Investments

You may not become a millionaire, but there is a lot to learn from George Soros.